Dr. Erin Tree @drtinytree.bsky.social · 30/10/2025It was great seeing so many people in person and learning together at #ACR25! Time to get back to this view 051
Dr. Erin Tree @drtinytree.bsky.social · 27/10/2025Got to meet the puppies at #ACR25! They are here until 4 today. 041
Dr. Erin Tree @drtinytree.bsky.social · 27/10/2025Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: sJIA treatment ⭐️cytokine monitoring, especially IL-18 ⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs #ACR25 #ACRambassador 022
Dr. Erin Tree @drtinytree.bsky.social · 27/10/2025Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: Window of opportunity ⭐️in non-systemic #JIA: ⬆️ inactive disease with earlier biologic start (<6mo) ⭐️in sJIA: integrating biomarkers in clinical care, early targeted tx #ACR25 #ACRambassador 142
Dr. Erin Tree @drtinytree.bsky.social · 27/10/2025Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis 4. Naming is important because guides therapy #ACR25 #ACRambassador #kidsgetarthritistoo 011
Dr. Erin Tree @drtinytree.bsky.social · 27/10/2025Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis 1. JIA classification has been a journey. Not every patient finds a home, & peds doesn’t consistently translate to adult classification. Is there a way to do this from a biologic basis? #ACR25 #ACRambassador 111
Dr. Erin Tree @drtinytree.bsky.social · 27/10/2025Looking forward to starting my day off in the Networking Lounges for the AMIGO event at 8:20 AM. Hope to see many fellow #pedsrheum there! #ACR25 #ACRambassador #pedsrheumsky 000
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Social Media 🚨 opportunity for increased healthcare provider engagement #ACRambassador 011
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Understanding Disease -ANA positive ITP patients have higher rates of SLE and Sjogren -Specific inborn errors of immunity are at increased risk of ANCA and AAV features #ACRambassador 111
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Guidelines -EULAR/PReS Still’s Guidelines -French protocol for treatment of #JIA -ACR Guidance for Mental Health #ACRambassador 111
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Medications -New FDA approvals: emapalumab, guselkumab -CAR-T cells in #JDM: a child with aggressive JDM achieved remission -Stem cell transplant: high morbidity, those who survive do well #ACRambassador 122
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Deprescribing -a large number of patients JIA flare off therapy -lower uveitis recurrence with slower ADA tapering schedule #ACRambassador 121
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Dr. Nigrovic presents #pedsrheum Basic & Translational Year in Review at #ACR25: 1. JIA 2. MAS 3. JDM 4. SLE 5. Monogenic diseases 011
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Calling all #pedsrheum researchers at #ACR25! Hope you can attend this evening's networking event from 4-5 PM. This event is particularly geared for early career investigators and fellows in training. #pedsrheumsky 011
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Drs. Linda Hiraki and Bonnie Bermas discuss applying 2025 SLE Guidelines to #cSLE ⭐️Peds specific GC dosing: GCs impact physical appearance ➡️ self-identity, mood ⭐️ Mental health screening is 🔑 ⭐️Impact on growth ⭐️Monitor school attendance/performance ⭐️Transition #ACR25 #ACRambassador #pedsrheumsky 022
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025The 2025 ACR extrarenal SLE guideline includes 36 graded recommendations 🔑HCQ= standard therapy 🔑GCs to control initial inflammation/flare; taper ASAP 🔑Early use of immunosuppressive therapies 🔑Shared decision making #ACR25 #ACRambassador 032
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025#ACR25 Clinical Year in Review by Dr. Bryant England (2/2): #Lupus ⭐️ 2024 lupus nephritis guidelines recommend triple therapy ⭐️ New option for 3rd therapy to treat lupus nephritis: obinutuzumab #ACRambassador 021
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025#ACR25 Clinical Year in Review by Dr. Bryant England (1/2): #Sjogren ⭐️ “The name has caught up to the science in Sjogren’s.” ⭐️ Potential role for salivary autoantibodies #ACRambassador 121
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025#ACR25 Basic Science Year in Review by Dr. Anne Davidson (3/3): Emerging conference themes ⭐️ CAR-T: upcoming sessions for #rheumsky and #pedsrheumsky ⭐️AI: resource provided for those interested in learning more #ACRambassador 011
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025#ACR25 Basic Science Year in Review by Dr. Anne Davidson (2/3): Take home messages about the progression of RA from preclinical to clinical state #ACRambassador 111
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025#ACR25 Basic Science Year in Review by Dr. Anne Davidson (1/3): 🔑 papers from the past 12 months #ACRambassador 111
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025Cutting it close to making the #ACR25 Year in Review. Of course today is the day Sapling decides to sleep in. 131
Dr. Erin Tree @drtinytree.bsky.social · 26/10/2025What a great start to #ACR25! The Opening Session featured a keynote by Dr. Tait Shanafelt, who spoke on the very relevant topic of clinician well-being. It was great seeing familiar faces at the grand opening networking event and at the @hspecialsurgery.bsky.social alumni event! #ACRambassador 040
Dr. Erin Tree @drtinytree.bsky.social · 18/11/2024Genetic testing in #pedsrheum by Dr. Troy Torgerson at #ACR24 ⭐️ Features 🚩 -Too young -Too much -Too weird -Combinations of above -Fam hx of immune dysregulation ⭐️ Reduced penetrance & variable expressivity are common features of PIRDS #ACRAmbassador 040
Dr. Erin Tree @drtinytree.bsky.social · 18/11/2024Good morning from #ACR24 ☀️ What session are you most excited for today? 010
Dr. Erin Tree @drtinytree.bsky.social · 17/11/2024Summary of treatment of Anti-MDA5 Juvenile Dermatomyositis, presented by Dr. Takayuki Kishi at #ACR24 ⭐️ IV CYC when concern for rapidly progressive ILD, but does every MDA5+ patient warrant this? ⭐️Rituximab and JAKi have demonstrated efficacy in MDA5+ JDM #ACRambassador #myositis #RheumSky 0153
Dr. Erin Tree @drtinytree.bsky.social · 17/11/2024Summary of clinical features of Anti-MDA5 Juvenile Dermatomyositis, presented by Dr. Lisa Rider at #ACR24 ⭐️ Systemic features, mild muscle disease, polyarthritis, cutaneous manifestations ⭐️Risk of ILD ⭐️Biomarkers to monitor disease activity #ACRambassador #myositis #RheumSky 0135
Dr. Erin Tree @drtinytree.bsky.social · 17/11/2024Good morning from #ACR24 ☀️ As you’re checking your agenda for today, don’t forget to add this networking event for #pedsrheum early career and fellows. 010
Dr. Erin Tree @drtinytree.bsky.social · 16/11/2024Is an approved treatment (or 2) on the horizon for #Sjogren disease? #ACR24 Year in Review: Targeting T cells through CD40/CD40L may be an effective biological approach to treating Sjogren disease #ACRambassador #RheumSky 0265
Dr. Erin Tree @drtinytree.bsky.social · 16/11/2024Can’t wait to share the work of the CARRA Juvenile Spondyloarthritis Workgroup at this morning’s #ACR24 poster session! Hope you can stop by our poster (and grab a friendship bracelet) #pedsrheum #juvenilearthritis #RheumSky #PedsRheumSky 030